Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (7)

1

Cardiac Injury in COVID-19-Echoing Prognostication

enthalten in: Journal of the American College of Cardiology | 2020

von Lavie, C. | Sanchis-Gomar, F. | Lippi, G.

CommentOn: J Am Coll Cardiol. 2020 Nov 3;76(18):2043-2055. - PMID 33121710

2

Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19

enthalten in: Journal of biological regulators and homeostatic agents | 2020

von Conti, P. | Caraffa, A. | Tetè, G. | +7

3

COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?

enthalten in: Journal of biological regulators and homeostatic agents | 2020

von Theoharides, T. | Conti, P.

4

IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi : inhibitory effect of the IL-1 receptor antagonist (IL-1Ra)

enthalten in: Journal of biological regulators and homeostatic agents | 2020

von Conti, P. | Caraffa, A. | Gallenga, C. | +7

5

Cannabis for COVID-19 : can cannabinoids quell the cytokine storm?

enthalten in: Future science OA | 2020

von Onaivi, E. | Sharma, V.

6

SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children : role of pro-inflammatory and anti-inflammatory cytokines

enthalten in: Journal of biological regulators and homeostatic agents | 2020

von Ronconi, G. | Teté, G. | Kritas, S. | +4

7

How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1

enthalten in: Journal of biological regulators and homeostatic agents | 2020

von Conti, P. | Gallenga, C. | Tetè, G. | +6

1
[1]